254 related articles for article (PubMed ID: 18289368)
1. Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.
Heath E; Tahri D; Andermarcher E; Schofield P; Fleming S; Boulter CA
BMC Dev Biol; 2008 Feb; 8():18. PubMed ID: 18289368
[TBL] [Abstract][Full Text] [Related]
2. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
3. The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine.
Perbal B
Expert Rev Mol Diagn; 2003 Sep; 3(5):597-604. PubMed ID: 14510180
[TBL] [Abstract][Full Text] [Related]
4. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
5. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.
Ivkovic S; Yoon BS; Popoff SN; Safadi FF; Libuda DE; Stephenson RC; Daluiski A; Lyons KM
Development; 2003 Jun; 130(12):2779-91. PubMed ID: 12736220
[TBL] [Abstract][Full Text] [Related]
7. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
8. NOV/CCN3 impairs muscle cell commitment and differentiation.
Calhabeu F; Lafont J; Le Dreau G; Laurent M; Kazazian C; Schaeffer L; Martinerie C; Dubois C
Exp Cell Res; 2006 Jun; 312(10):1876-89. PubMed ID: 16600215
[TBL] [Abstract][Full Text] [Related]
9. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
10. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
[TBL] [Abstract][Full Text] [Related]
11. NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival.
Lafont J; Thibout H; Dubois C; Laurent M; Martinerie C
Cell Commun Adhes; 2005; 12(1-2):41-57. PubMed ID: 16371345
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
13. CYR61 (CCN1) is essential for placental development and vascular integrity.
Mo FE; Muntean AG; Chen CC; Stolz DB; Watkins SC; Lau LF
Mol Cell Biol; 2002 Dec; 22(24):8709-20. PubMed ID: 12446788
[TBL] [Abstract][Full Text] [Related]
14. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
15. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
17. Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
Croci S; Landuzzi L; Nicoletti G; Palladini A; Antognoli A; De Giovanni C; Nanni P; Lollini PL
Pathol Oncol Res; 2007; 13(4):336-9. PubMed ID: 18158569
[TBL] [Abstract][Full Text] [Related]
18. Proposal for a unified CCN nomenclature.
Brigstock DR; Goldschmeding R; Katsube KI; Lam SC; Lau LF; Lyons K; Naus C; Perbal B; Riser B; Takigawa M; Yeger H
Mol Pathol; 2003 Apr; 56(2):127-8. PubMed ID: 12665631
[TBL] [Abstract][Full Text] [Related]
19. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
20. A role for CCN3 (NOV) in calcium signalling.
Li CL; Martinez V; He B; Lombet A; Perbal B
Mol Pathol; 2002 Aug; 55(4):250-61. PubMed ID: 12147716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
